Diabetes is a very common cause of kidney failure. Studies have shown that identifying diabetics in the very early stages of kidney disease by demonstrating an abnormal albumin:creatinine ratio (ACR) helps patients and doctors adjust treatment. With better diabetic control and better control of other complications, such as high blood pressure, the progression of diabetic kidney disease can be slowed down or prevented.
Albumin is the principal component of proteinuria in glomerular disease. Reagent strips in current clinical practice predominantly detect albumin, not total protein, but are not reliably quantitative. ACR has far greater sensitivity than protein:creatinine ratio (PCR) for the detection of low levels of proteinuria and enhances early identification of CKD. However, there may be clinical reasons for a specialist to subsequently use PCR to quantify and monitor significant levels of proteinuria.
To detect and identify proteinuria, use urine albumin:creatinine ratio (ACR) in preference, as it has greater sensitivity than PCR for low levels of proteinuria.
Early morning urine sample preferable
The urine protein:creatinine ratio is calculated as follows:
(Urine protein(g/L) X 1000)/Urine creatinine(mmol/L)
*Please note this assay is not currently included in our accreditation scope*